AhmetUluerDOMPH
Pulmonology • Boston, MACystic Fibrosis
Assistant Professor, Boston Children's and Brigham & Women's Hospital, Harvard Medical School
Dr. Uluer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Children's Hospital Boston, Mailstop 208
Boston, MA 02115Phone+1 617-355-6105Fax+1 617-730-0084
Education & Training
Harvard School of Public HealthMPH, Health Care Management, Clinical Effectiveness, 2015 - 2018
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Pulmonology, 2003 - 2006
Cleveland Clinic FoundationChief Residency, Internal Medicine/Pediatrics, 2002 - 2003- Cleveland Clinic FoundationResidency, Internal Medicine/Pediatrics, 1999 - 2003
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1999
University of MichiganBS, Biology, 1987 - 1991
Certifications & Licensure
MA State License 2005 - 2025
OH State License 1999 - 2003- American Board of Pediatrics Pediatric Pulmonology
- American Board of PediatricsPulmonology
Clinical Trials
- Structure and Function of Salivary Proteins Start of enrollment: 2007 Nov 01
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Increase Tolerance for Exercise and Raise Activity Through Connectedness Trial Start of enrollment: 2016 Mar 14
- Join now to see all
Publications & Presentations
PubMed
- 577 citationsEffect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR MutationFrank J. Accurso, Steven M. Rowe, John P. Clancy, Michael P. Boyle, Jordan M. Dunitz
The New England Journal of Medicine. 2010-11-18 - 4 citationsRandomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.Jordan S Sherwood, Luz E Castellanos, Mollie Y O'Connor, Courtney A Balliro, Mallory A Hillard
Diabetes Care. 2024-01-01 - 1 citationsContinuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with...Kevin J Scully, Laura Brenner, Kimberly Martin, Melanie Ruazol, Gregory S Sawicki
Frontiers in Endocrinology. 2024-01-01
Journal Articles
- VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del AllelesAhmet Uluer, Bonnie W Ramsey, The New England Journal of Medicine
Press Mentions
Every Breath You Take: The Life of a Lung TransplantJune 4th, 2021- Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) to Provide Increased Funding and Support for ELX-02 Global Phase 2 Clinical Trial ProgramJanuary 13th, 2021
- Eloxx Pharmaceuticals Reports Third Quarter 2020 Financial and Operating Results and Provides Business UpdateNovember 5th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
